Target intelligence / Profile preview

Gastrointestinal lipase

Molecular classification
Enzyme, Hydrolase, Alpha/beta-hydrolase fold superfamily
01

Overview

Gastrointestinal lipase encompasses several types of lipase enzymes that function in the digestive tract to break down dietary fats. The main types include lingual lipase (secreted in saliva), gastric lipase (secreted by gastric chief cells in the stomach), and pancreatic lipase (secreted by the pancreas into the small intestine). These enzymes catalyze the hydrolysis of triglycerides into free fatty acids and glycerol, enabling fat digestion and absorption. Gastric lipase works optimally at acidic pH (3-6) and doesn't require bile acids or colipase for activity, while pancreatic lipase is the most important lipolytic enzyme, responsible for hydrolyzing most dietary fats. Pancreatic lipase has a catalytic triad consisting of serine, aspartic acid, and histidine residues that form the active site for substrate hydrolysis. In adults, acidic lipases (gastric and lingual) contribute about 30% of total lipid hydrolysis, while in infants they provide up to 50% of lipolytic activity due to underdeveloped pancreatic function. Deficiencies in these enzymes can lead to malnutrition and digestive disorders, particularly in conditions like cystic fibrosis where pancreatic enzyme secretion is impaired.

Other names
Digestive lipaseFat-digesting enzymeLipolytic enzyme
02

Mechanism of action

Hydrolysis of ester bonds in triglycerides to produce free fatty acids and glycerol

03

Biological functions

Lipid metabolismDigestionNutrient absorptionFat transport
04

Disease associations

MalnutritionCystic fibrosisCrohn's diseaseCeliac diseaseIndigestionIrritable bowel syndromeGastric cancer
05

Safety considerations

Interference with lipase supplements by medications like OrlistatDestruction of lipase enzymes by digestive enzymes including papain, pepsin, betaine HCL, and hydrochloric acid
06

Interacting drugs

Orlistat (Xenical, Alli)
07

Biomarkers

Lipase levels in blood (elevated in pancreatic disorders)

Beyond the preview

Go deeper on Gastrointestinal lipase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal lipase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call